The Gross Margin of Fusen Pharmaceutical Co Ltd (1652.HK) is 49.88%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 49.88% |
| 2023-12-31 | 52.95% |
| 2022-12-31 | 45.76% |
| 2021-12-31 | 54.75% |
| 2020-12-31 | 54.65% |
| 2019-12-31 | 52.16% |
| 2018-12-31 | 54.39% |
| 2017-12-31 | 55.67% |
| 2016-12-31 | 50.27% |
| 2015-12-31 | 47.01% |